
AdvaMed, Medtech Leaders From Across the Country Meet with Lawmakers This Week
Senate committee passage of Medical Device User Fee Amendments legislation is an important step toward improving FDA review of medical technology to help patients.
Senate committee passage of Medical Device User Fee Amendments legislation is an important step toward improving FDA review of medical technology to help patients.
Senate committee passage of Medical Device User Fee Amendments legislation is an important step toward improving FDA review of medical technology to help patients.
The Advanced Medical Technology Association (AdvaMed) welcomes House passage of the MDUFA V agreement.
Scott Whitaker, president and CEO of AdvaMed, the world’s largest trade association representing medical technology companies, released the following statement on progress this week in both houses of Congress.
Following the release of the House Energy and Commerce Committee’s FDA User Fees Legislative Package, the Advanced Medical Technology Association (AdvaMed) released this statement from President and CEO Scott Whitaker.
AdvaMed’s PAC is the voluntary, bi-partisan Political Action Committee (PAC) of the Advanced Medical Technology Association.
Scott Whitaker, President and CEO of AdvaMed, led a meeting of medtech CEOs and leaders with Secretary of Commerce Gina Raimondo to discuss semiconductor chip supply chain issues impacting the…
On patient safety, there is no substitution for the extensive training, knowledge, and expertise authorized servicers must have to maintain and repair complex medical technology.
Congress is considering the latest agreement between the FDA and the industry to help fund agency consideration of medical devices with user fees.
Today, AdvaMed President and CEO Scott Whitaker issued a statement following the White House’s announcement that the federal government’s COVID-19 response would be reduced in the coming weeks without additional…